PIN-3
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old (NCT05518201) | Shanghai Bovax Biotechnology Co., Ltd. | 2022-09-23 |
Track PIN-3 automatically
Every clearance here is in the API, with alerts when new ones post.